Nacl + Glucose Viaflo Baxter (Sodium Chloride, Glucose)

Sodium chloride and glucose, the active ingredient in Nacl + Glucose Viaflo Baxter, is an electrolyte solution presented as an injection solution for intravenous use. It helps restore extracellular fluid volume, correct electrolyte imbalances, and provide an energy substrate in patients requiring fluid and electrolyte replacement.

GNH USA supplies Nacl + Glucose Viaflo Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide, with the product sourced from EU manufacturers.

Nacl + Glucose Viaflo Baxter, an intravenous electrolyte solution, is used in clinical situations that require fluid and electrolyte replacement.

- Fluid replacement: restores intravascular volume in patients with dehydration, blood loss or burns. - Electrolyte replenishment: corrects sodium and chloride deficits during surgery or illness. - Prevention or treatment of hypoglycemia: supplies glucose as an immediate energy source for patients with low blood sugar. - Peri‑operative fluid management: maintains hemodynamic stability during surgical procedures.

Adverse reactions may occur with any intravenous solution. Monitoring and appropriate administration techniques reduce risk.

Common Side Effects: - Injection site pain: discomfort at the infusion site. - Phlebitis: inflammation of the vein used for administration. - Mild hypernatremia: slight elevation of serum sodium levels. - Transient hyperglycemia: temporary increase in blood glucose.

Serious or Rare Side Effects: - Severe hypernatremia: marked elevation of serum sodium that can cause neurological symptoms. - Allergic reaction (anaphylaxis): rare but potentially life‑threatening hypersensitivity. - Fluid overload leading to pulmonary edema: excess volume accumulation in the lungs. - Electrolyte imbalance (hypokalemia): low potassium secondary to rapid sodium shifts.

Careful assessment and monitoring are essential when using this intravenous solution.

- Assess fluid status: evaluate patient’s volume status before administration. - Monitor electrolytes: check serum sodium and glucose levels during therapy. - Renal function: consider reduced clearance in patients with impaired kidney function. - Cardiac status: avoid rapid infusion in individuals with heart failure or uncontrolled hypertension. - Store at ambient temperature: keep in original packaging, protect from light and moisture.

Potential drug interactions should be reviewed before initiating therapy.

Major Interactions (Avoid): - Hypertonic saline solutions: concurrent use may cause severe hypernatremia. - Insulin therapy: combined high‑glucose infusion may require insulin dose adjustment. - Diuretics: may exacerbate electrolyte shifts.

Moderate Interactions (Monitor Closely): - ACE inhibitors: monitor blood pressure and potassium levels. - Beta‑blockers: watch for signs of fluid overload. - Corticosteroids: may increase sodium retention and affect fluid balance.